Your fact-checks will appear here
Current evidence on honey's neuroprotective properties and potential as an adjunct to existing dementia therapies
Clinical evidence directly testing honey or honey-derived compounds for cognitive decline in humans is sparse and heterogeneous: major recent reviews conclude there are no completed randomized control...
Peer‑reviewed human clinical evidence testing honey or isolated honey compounds specifically for cognitive decline is extremely limited: systematic reviews and recent narrative reviews report no compl...
Sidr honey contains a mix of polyphenols and flavonoids—compounds long associated with antioxidant, anti-inflammatory and enzyme-modulating activity—that experimental studies of various honeys link to...
The human clinical-trial evidence testing honey specifically for Alzheimer’s disease is sparse, mixed, and disputed in the literature: several recent systematic reviews assert that no randomized, regi...